Danaher Corporation ( DHR) - Stock Earnings
DHR Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| July 21, 2026 BeforeMarket | 1.94 / — | — | 6.3 billion / — | — |
DHR Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 908.0 million USD | 6.1 billion USD |
| 2025Q4 | 1.2 billion USD | 6.8 billion USD |
| 2026Q1 | 1.0 billion USD | 6.0 billion USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
DHR Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 4.7 billion USD | 23.9 billion USD |
| 2024 | 3.9 billion USD | 23.9 billion USD |
| 2025 | 3.6 billion USD | 24.6 billion USD |
| 2026 Est. | — | — |
DHR
List: Contenders
Price: $166.37
Dividend Yield: 0.73%
Forward Dividend Yield: 0.80%
Payout Ratio: 19.89%
Dividend Per Share: 1.60 USD
Earnings Per Share: 5.16 USD
P/E Ratio: 34.35
Exchange: NYQ
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 1.8 million
Ebitda: 1.3 billionMarket Capitalization: 140.1 billion
Average Dividend Frequency: 4
Years Paying Dividends: 34
DGR3: 8.80%
DGR5: 11.15%
DGR10: 30.00%
DGR20: 30.00%